Tvardi Therapeutics (TVRD) Profit After Tax: 2012-2016
Historic Profit After Tax for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to -$57.3 million.
- Tvardi Therapeutics' Profit After Tax fell 7.81% to -$12.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$65.9 million, marking a year-over-year decrease of 47.01%. This contributed to the annual value of -$57.3 million for FY2016, which is 132.00% down from last year.
- Per Tvardi Therapeutics' latest filing, its Profit After Tax stood at -$57.3 million for FY2016, which was down 132.00% from -$24.7 million recorded in FY2015.
- Over the past 5 years, Tvardi Therapeutics' Profit After Tax peaked at -$4.0 million during FY2013, and registered a low of -$57.3 million during FY2016.
- Over the past 3 years, Tvardi Therapeutics' median Profit After Tax value was -$24.7 million (recorded in 2015), while the average stood at -$33.2 million.
- In the last 5 years, Tvardi Therapeutics' Profit After Tax soared by 36.80% in 2013 and then tumbled by 347.77% in 2014.
- Over the past 5 years, Tvardi Therapeutics' Profit After Tax (Yearly) stood at -$6.3 million in 2012, then skyrocketed by 36.80% to -$4.0 million in 2013, then tumbled by 347.77% to -$17.7 million in 2014, then slumped by 39.14% to -$24.7 million in 2015, then plummeted by 132.00% to -$57.3 million in 2016.